Managing and Preventing Neurotrophic Keratopathy after Laser Vision Correction

Abstract

A 45-year-old male presents for a refractive surgery consult with past medical history of a nasal tumor removal from the right sinus. His current regimen consists of icosapent ethyl (2g by mouth twice daily) for treatment of hypertriglyceridemia and lisinopril (10mg by mouth once daily) for treatment of hypertension. Patient’s BCVA is 20/20 OU with a manifest refraction of -4.25 +1.00 x 157º OD and -3.00 +0.25 x 035º OS. He wore contact lenses with a defocus of -0.50 D OD for near and a full correction OS for distance. Schirmer 1 test (anesthetized) shows 14 mm OD and 12 mm OS [1]. Corneal sensation OD was depressed while the OS was normal, and the patient did not report history of dry eye disease (Figure 1).